Amber Allen

NeonMind Biosciences, Inc. focuses in drug development to evaluate the safety and efficacy of psychedelic substances for therapeutic uses as approved medicines. It operates through the Pharmaceutical, and Consumer divisions. The Pharmaceutical division deals with drug development of psychedelic compounds and a consumer products division with a focus on mushroom infused products including functional foods, natural health products, and dietary supplements. The Consumer divisions engages in the sale of four branded coffee products in Canada through NeonMind's direct to consumer e-commerce platform. The company was founded by Jeff B. Smith and Penny White in 2019 and is headquartered in Vancouver, Canada.